Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Recludix Pharma
Biotech
Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders
Sarepta shakes up C-suite amid organization overhaul. BioNTech strategy chief seeks new adventure. Prime’s CSO hits the exit.
Darren Incorvaia
,
Zoey Becker
Jul 18, 2025 8:30am
Introducing Fierce Biotech's 2024 Fierce 15
Aug 5, 2024 6:00am
Sanofi pays $125M, offers up to $1.2B biobucks for Recludix deal
Jul 20, 2023 8:00am
Moderna promotes Andres to new strategy role—Chutes & Ladders
Sep 30, 2022 9:30am
FDA Califf, Biogen exec Sandrock, Pfizer CFO—Chutes & Ladders
Nov 19, 2021 9:30am
Recludix emerges with $60M, Seagen exec Nancy Whiting at helm
Nov 15, 2021 8:00am
